Accendra Health Pre-Tax Profit Margin 2012-2026 | ACH
Accendra Health pre-tax profit margin from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Accendra Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-03-31 | $0.76B | $-0.08B | -10.95% |
| 2025-12-31 | $2.76B | $-0.10B | -3.69% |
| 2025-09-30 | $10.75B | $-0.45B | -4.15% |
| 2025-06-30 | $10.74B | $-0.44B | -4.11% |
| 2025-03-31 | $10.72B | $-0.37B | -3.40% |
| 2024-12-31 | $10.70B | $-0.36B | -3.34% |
| 2024-09-30 | $6.62B | $-0.01B | -0.21% |
| 2024-06-30 | $8.52B | $-0.03B | -0.31% |
| 2024-03-31 | $10.42B | $-0.05B | -0.46% |
| 2023-12-31 | $10.33B | $-0.06B | -0.53% |
| 2023-09-30 | $10.23B | $-0.17B | -1.67% |
| 2023-06-30 | $10.13B | $-0.14B | -1.38% |
| 2023-03-31 | $10.07B | $-0.07B | -0.70% |
| 2022-12-31 | $9.96B | $0.01B | 0.11% |
| 2022-09-30 | $9.87B | $0.16B | 1.58% |
| 2022-06-30 | $9.88B | $0.19B | 1.89% |
| 2022-03-31 | $9.87B | $0.23B | 2.36% |
| 2021-12-31 | $9.79B | $0.28B | 2.83% |
| 2021-09-30 | $9.68B | $0.30B | 3.06% |
| 2021-06-30 | $9.37B | $0.30B | 3.18% |
| 2021-03-31 | $8.69B | $0.22B | 2.52% |
| 2020-12-31 | $8.48B | $0.11B | 1.30% |
| 2020-09-30 | $8.31B | $0.03B | 0.40% |
| 2020-06-30 | $8.42B | $-0.02B | -0.21% |
| 2020-03-31 | $8.98B | $-0.03B | -0.38% |
| 2019-12-31 | $9.21B | $-0.03B | -0.31% |
| 2019-09-30 | $9.14B | $-0.27B | -2.94% |
| 2019-06-30 | $9.32B | $-0.27B | -2.93% |
| 2019-03-31 | $9.40B | $-0.45B | -4.82% |
| 2018-12-31 | $9.42B | $-0.43B | -4.53% |
| 2018-09-30 | $9.69B | $-0.20B | -2.03% |
| 2018-06-30 | $9.56B | $-0.17B | -1.82% |
| 2018-03-31 | $9.36B | $0.04B | 0.46% |
| 2017-12-31 | $9.32B | $0.06B | 0.62% |
| 2017-09-30 | $9.30B | $0.12B | 1.27% |
| 2017-06-30 | $9.38B | $0.14B | 1.54% |
| 2017-03-31 | $9.60B | $0.16B | 1.70% |
| 2016-12-31 | $9.72B | $0.17B | 1.77% |
| 2016-09-30 | $9.84B | $0.18B | 1.84% |
| 2016-06-30 | $9.90B | $0.18B | 1.83% |
| 2016-03-31 | $9.84B | $0.18B | 1.80% |
| 2015-12-31 | $9.77B | $0.17B | 1.77% |
| 2015-09-30 | $9.78B | $0.16B | 1.60% |
| 2015-06-30 | $9.69B | $0.13B | 1.29% |
| 2015-03-31 | $9.58B | $0.12B | 1.23% |
| 2014-12-31 | $9.44B | $0.13B | 1.35% |
| 2014-09-30 | $9.27B | $0.14B | 1.52% |
| 2014-06-30 | $9.15B | $0.17B | 1.87% |
| 2014-03-31 | $9.08B | $0.18B | 2.03% |
| 2013-12-31 | $9.07B | $0.19B | 2.05% |
| 2013-09-30 | $9.04B | $0.18B | 1.99% |
| 2013-06-30 | $8.95B | $0.18B | 1.99% |
| 2013-03-31 | $8.90B | $0.18B | 2.03% |
| 2012-12-31 | $8.87B | $0.18B | 2.07% |
| 2012-09-30 | $8.78B | $0.18B | 2.06% |
| 2012-06-30 | $8.78B | $0.19B | 2.19% |
| 2012-03-31 | $8.72B | $0.19B | 2.18% |
| 2011-12-31 | $8.63B | $0.19B | 2.19% |
| 2011-09-30 | $8.50B | $0.19B | 2.19% |
| 2011-06-30 | $8.39B | $0.18B | 2.18% |
| 2011-03-31 | $8.28B | $0.18B | 2.22% |
| 2010-12-31 | $8.12B | $0.18B | 2.25% |
| 2010-09-30 | $8.09B | $0.20B | 2.47% |
| 2010-06-30 | $8.07B | $0.20B | 2.49% |
| 2010-03-31 | $8.06B | $0.20B | 2.46% |
| 2009-12-31 | $8.04B | $0.19B | 2.35% |
| 2009-09-30 | $7.96B | $0.18B | 2.28% |
| 2009-06-30 | $7.71B | $0.17B | 2.18% |
| 2009-03-31 | $7.47B | $0.16B | 2.17% |
| 2008-12-31 | $7.24B | $0.16B | 2.26% |
| 2008-09-30 | $6.93B | $0.15B | 2.21% |
| 2008-06-30 | $6.83B | $0.15B | 2.18% |
| 2008-03-31 | $6.74B | $0.14B | 2.06% |
| 2007-12-31 | $6.70B | $0.12B | 1.76% |
| 2007-09-30 | $6.61B | $0.10B | 1.56% |
| 2007-06-30 | $6.24B | $0.09B | 1.44% |
| 2007-03-31 | $5.87B | $0.08B | 1.31% |
| 2006-12-31 | $5.44B | $0.09B | 1.58% |
| 2006-09-30 | $5.10B | $0.09B | 1.82% |
| 2006-06-30 | $4.98B | $0.10B | 1.97% |
| 2006-03-31 | $4.89B | $0.11B | 2.19% |
| 2005-12-31 | $4.82B | $0.11B | 2.20% |
| 2005-09-30 | $4.77B | $0.11B | 2.20% |
| 2005-06-30 | $4.70B | $0.10B | 2.17% |
| 2005-03-31 | $4.61B | $0.10B | 2.19% |
| 2004-12-31 | $4.52B | $0.10B | 2.19% |
| 2004-09-30 | $4.47B | $0.10B | 2.17% |
| 2004-06-30 | $4.40B | $0.09B | 2.12% |
| 2004-03-31 | $4.33B | $0.09B | 2.08% |
| 2003-12-31 | $4.25B | $0.09B | 2.05% |
| 2003-09-30 | $4.16B | $0.09B | 2.09% |
| 2003-06-30 | $4.09B | $0.08B | 2.06% |
| 2003-03-31 | $4.01B | $0.08B | 2.02% |
| 2002-12-31 | $3.96B | $0.08B | 1.97% |
| 2002-09-30 | $3.91B | $0.06B | 1.56% |
| 2002-06-30 | $3.88B | $0.06B | 1.52% |
| 2002-03-31 | $3.86B | $0.06B | 1.48% |
| 2001-12-31 | $3.82B | $0.05B | 1.39% |
| 2001-09-30 | $3.74B | $0.07B | 1.74% |
| 2001-06-30 | $3.65B | $0.06B | 1.75% |
| 2001-03-31 | $3.57B | $0.06B | 1.74% |
| 2000-12-31 | $3.50B | $0.06B | 1.71% |
| 2000-09-30 | $3.47B | $0.06B | 1.67% |
| 2000-06-30 | $3.41B | $0.06B | 1.64% |
| 2000-03-31 | $3.30B | $0.05B | 1.61% |
| 1999-12-31 | $3.19B | $0.05B | 1.60% |
| 1999-09-30 | $3.04B | $0.05B | 1.55% |
| 1999-06-30 | $3.00B | $0.05B | 1.50% |
| 1999-03-31 | $3.03B | $0.03B | 1.09% |
| 1998-12-31 | $3.08B | $0.03B | 1.10% |
| 1998-09-30 | $3.17B | $0.03B | 1.07% |
| 1998-06-30 | $3.19B | $0.03B | 1.07% |
| 1998-03-31 | $3.17B | $0.04B | 1.39% |
| 1997-12-31 | $3.12B | $0.04B | 1.35% |
| 1997-09-30 | $3.07B | $0.04B | 1.27% |
| 1997-06-30 | $3.03B | $0.04B | 1.16% |
| 1997-03-31 | $3.00B | $0.03B | 1.00% |
| 1996-12-31 | $3.02B | $0.02B | 0.79% |
| 1996-09-30 | $3.01B | $0.01B | 0.20% |
| 1996-06-30 | $3.01B | $-0.01B | -0.47% |
| 1996-03-31 | $3.00B | $-0.02B | -0.53% |
| 1995-12-31 | $2.98B | $-0.02B | -0.54% |
| 1995-09-30 | $2.96B | $0.00B | 0.14% |
| 1995-06-30 | $2.91B | $0.02B | 0.69% |
| 1995-03-31 | $2.75B | $0.01B | 0.33% |
| 1994-12-31 | $2.40B | $0.01B | 0.58% |
| 1994-09-30 | $2.04B | $0.01B | 0.59% |
| 1994-06-30 | $1.71B | $0.02B | 0.99% |
| 1994-03-31 | $1.47B | $0.03B | 2.18% |
| 1993-12-31 | $1.40B | $0.03B | 2.15% |
| 1993-09-30 | $1.33B | $0.03B | 2.19% |
| 1993-06-30 | $1.26B | $0.03B | 2.22% |
| 1993-03-31 | $1.21B | $0.03B | 2.23% |
| 1992-12-31 | $1.18B | $0.03B | 2.21% |
| 1992-09-30 | $0.93B | $0.02B | 2.16% |
| 1992-06-30 | $0.96B | $0.02B | 1.98% |
| 1992-03-31 | $0.99B | $0.02B | 1.81% |
| 1991-12-31 | $1.02B | $0.02B | 1.66% |
| 1991-09-30 | $1.00B | $0.02B | 1.51% |
| 1991-06-30 | $0.97B | $0.01B | 1.34% |
| 1991-03-31 | $0.95B | $0.01B | 1.16% |
| 1990-12-31 | $0.93B | $0.01B | 1.07% |
| 1990-09-30 | $0.95B | $0.01B | 0.74% |
| 1990-06-30 | $0.90B | $0.01B | 0.56% |
| 1990-03-31 | $0.82B | $0.00B | 0.24% |
| 1989-12-31 | $0.72B | $0.00B | 0.14% |
| 1989-09-30 | $0.87B | $0.01B | 0.92% |
| 1989-06-30 | $0.79B | $0.01B | 1.26% |
| 1989-03-31 | $0.75B | $0.01B | 1.73% |
| 1988-12-31 | $0.73B | $0.01B | 1.91% |
| 1988-09-30 | $0.70B | $0.01B | 2.00% |
| 1988-06-30 | $0.66B | $0.01B | 1.97% |
| 1988-03-31 | $0.62B | $0.01B | 1.93% |
| 1987-12-31 | $0.58B | $0.01B | 1.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.245B | $2.735B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $152.983B | 16.86 |
| Stryker (SYK) | United States | $116.806B | 22.75 |
| Medtronic (MDT) | Ireland | $101.469B | 14.34 |
| EssilorLuxottica (ESLOY) | France | $89.470B | 0.00 |
| Boston Scientific (BSX) | United States | $65.890B | 14.30 |
| Medline (MDLN) | United States | $45.598B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.521B | 0.00 |
| Agilent Technologies (A) | United States | $35.725B | 21.77 |
| GE HealthCare Technologies (GEHC) | United States | $27.585B | 13.30 |
| ResMed (RMD) | United States | $27.336B | 17.50 |
| Koninklijke Philips (PHG) | Netherlands | $26.518B | 15.42 |
| Terumo (TRUMY) | Japan | $20.489B | 22.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $16.849B | 10.27 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.494B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.510B | 0.00 |
| Baxter (BAX) | United States | $10.154B | 9.45 |
| Insulet (PODD) | United States | $9.626B | 25.83 |
| Demant (WILYY) | Denmark | $8.153B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.523B | 30.33 |
| Lantheus Holdings (LNTH) | United States | $6.914B | 21.33 |
| BillionToOne (BLLN) | United States | $4.633B | 0.00 |
| Envista Holdings (NVST) | United States | $4.151B | 19.33 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.062B | 0.00 |
| ICU Medical (ICUI) | United States | $3.403B | 21.44 |
| Haemonetics (HAE) | United States | $3.296B | 14.59 |
| Curaleaf Holdings (CURLD) | Canada | $2.248B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.154B | 10.35 |
| GN Store Nord (GNNDY) | Denmark | $2.053B | 97.19 |
| LeMaitre Vascular (LMAT) | United States | $2.025B | 34.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.951B | 0.00 |
| Neogen (NEOG) | United States | $1.942B | 42.48 |
| Capricor Therapeutics (CAPR) | United States | $1.699B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.522B | 16.27 |
| AtriCure (ATRC) | United States | $1.440B | 948.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.328B | 3.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 33.31 |
| Phibro Animal Health (PAHC) | United States | $1.260B | 10.60 |
| BioLife Solutions (BLFS) | United States | $1.217B | 207.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.210B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.912B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.844B | 9.23 |
| InMode (INMD) | Israel | $0.759B | 9.57 |
| Omeros (OMER) | United States | $0.748B | 4.74 |
| CeriBell (CBLL) | United States | $0.690B | 0.00 |
| Brainsway (BWAY) | Israel | $0.577B | 41.09 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Cerus (CERS) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.508B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.472B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.438B | 10.95 |
| Evolus (EOLS) | United States | $0.434B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.417B | 29.38 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.392B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.360B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 17.46 |
| MacroGenics (MGNX) | United States | $0.291B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Village Farms (VFF) | Canada | $0.214B | 8.50 |
| Utah Medical Products (UTMD) | United States | $0.211B | 19.57 |
| High Tide (HITI) | Canada | $0.201B | 57.25 |
| Sanara MedTech (SMTI) | United States | $0.199B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.198B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.176B | 47.83 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quanterix (QTRX) | United States | $0.164B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.164B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.102B | 13.71 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| ImmuCell (ICCC) | United States | $0.088B | 0.00 |
| Biote (BTMD) | United States | $0.085B | 5.11 |
| Hongchang (HCIL) | China | $0.081B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.077B | 27.30 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.035B | 46.57 |
| United-Guardian (UG) | United States | $0.032B | 13.46 |
| Rockwell Medical (RMTI) | United States | $0.026B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.026B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Jin Medical (ZJYL) | China | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Akanda (AKAN) | Canada | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| INLIF (INLF) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |